Genvor's Antimicrobial Peptides Advance into Sugar Beet Research

Genvor’s Antimicrobial Peptides Advance into Sugar Beet Research

Collaborating with USDA-ARS to Combat Microbial Threats in Production, Storage, and Processing

Woodland, CA — July 27, 2026

Genvor, Inc. (OTCQB: GNVR), a biotechnology company utilizing AI to generate novel peptide solutions, announced on July 27, 2026, that its proprietary antimicrobial peptides are being evaluated under the ARS Sustainable Sugar Beet Research Initiative. The collaboration aims to address critical microbial challenges in sugar beet production, storage, and processing.

Tackling Storage and Processing Losses

Microbial activity during storage and downstream processing often degrades sugar recovery, product quality, and overall operational efficiency. Through this project, USDA-ARS researchers are assessing whether Genvor’s antimicrobial peptides can effectively inhibit key microbes responsible for sugar root rot and extraction inefficiencies.

“Sugar beet production is a meaningful new area where Genvor’s antimicrobial peptides can support growers, processors, and the broader agricultural value chain.”

— Dr. George Stavrides, Executive Vice President, Business Development & Commercialization, Genvor

Powered by AI and Proprietary Platforms

Powered by its proprietary BioCypher™ platform, Genvor designs short protein molecules that target microbial and physiological challenges across agriculture and human health. Co-founder Dr. Jesse Jaynes noted that extending these peptide applications into sugar beet systems allows the team to target a new set of microbial threats and further validate the scalability of peptide science.

“Translating years of peptide research into real agricultural solutions.”